THERAPEUTIC POTENTIAL OF ASPIRIN IN CANCER OF THE COLON

被引:6
|
作者
MORGAN, GP
WILLIAMS, JG
机构
来源
BRITISH MEDICAL JOURNAL | 1993年 / 307卷 / 6910期
关键词
D O I
10.1136/bmj.307.6910.1007-b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1007 / 1008
页数:2
相关论文
共 50 条
  • [41] Pattern of aspirin use and colon cancer risk.
    Yang, J
    Moysich, K
    McCann, S
    Natarajan, N
    Ambrosone, C
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1928S - 1928S
  • [42] Does aspirin really reduce the risk of colon cancer?
    Jankowski, Janusz
    Barr, Hugh
    Moayyedi, Paul
    LANCET, 2012, 379 (9826): : 1586 - 1587
  • [43] ASPIRIN USE AND REDUCED RISK OF FATAL COLON CANCER
    DEUTSCH, ME
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19): : 1289 - 1289
  • [44] Effects on colon cancer risk in randomised trials of aspirin
    Rothwell, P.
    ECANCERMEDICALSCIENCE, 2011, 5
  • [45] Aspirin should not be promoted for colon cancer prevention: Counterpoint
    Sandler, Robert S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (07) : 1562 - 1563
  • [46] Another boost for aspirin in improving colon cancer mortality
    不详
    COLORECTAL CANCER, 2012, 1 (03) : 199 - 199
  • [47] Aspirin, Statins and Molecular Pathological Epidemiology of Colon Cancer
    Loughrey, M. B.
    Coleman, H. G.
    JOURNAL OF PATHOLOGY, 2018, 246 : S9 - S9
  • [48] An aspirin a day may not keep colon cancer at bay
    Bonn, D
    LANCET, 1998, 351 (9112): : 1334 - 1334
  • [49] Exploring the Molecular Targets and Therapeutic Potential of Coptisine in Colon Cancer: A Network Pharmacology Approach
    Yang, Jing
    Tao, Qing
    Li, Jun
    Xie, Yang
    Tang, Chaotao
    Huang, Xia
    Chen, Youxiang
    Zeng, Chunyan
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [50] Nuclear factor-kappa B as potential therapeutic target in human colon cancer
    Plewka, Danuta
    Plewka, Andrzej
    Miskiewicz, Adam
    Morek, Michal
    Bogunia, Edyta
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (03) : 516 - 520